1-β-D-Arabinofuranosyluracil CAS:3083-77-0

1-β-D-Arabinofuranosyluracil, also known as 1-β-D-Arabinofuranosylcytosine or simply ara-C, is a nucleoside analog that is used as a chemotherapy medication to treat cancer. It is particularly effective against leukemia and lymphoma by interfering with the growth and spread of cancer cells in the body.

The mechanism of action involves ara-C being incorporated into the DNA of cancer cells, which disrupts the DNA synthesis process and ultimately leads to cell death. Ara-C is often used as part of combination chemotherapy regimens and may be administered intravenously.

The application of 1-β-D-Arabinofuranosyluracil in clinical settings is primarily for the treatment of various forms of leukemia and lymphoma.